Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Schisandrin B Inhibits Osteoclastogenesis and Protects Against Ovariectomy-Induced Bone Loss

Published:2020-07-31 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Wang Jia,Fang Zhong,Song Chao,Kang Honglei,Guo Qian,Dong Yimin,Zhang Ya,Peng Renpeng,Guan Hanfeng,Li Feng

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference46 articles.

1. Schisandrin B attenuates pressure overload-induced cardiac remodeling in mice by inhibiting the MAPK signaling pathway;Ai;Exp. Ther. Med.,2019

2. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors;Arai;J. Exp. Med.,1999

3. The molecular understanding of osteoclast differentiation;Asagiri;Bone,2007

4. The underlying pathophysiology and therapeutic approaches for osteoporosis;Awasthi;Med. Res. Rev.,2018

5. Osteoclast differentiation and activation;Boyle;Nature,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis;Cell Metabolism;2024-08

2. Catalpol from Rehmannia glutinosa Targets Nrf2/NF-κB Signaling Pathway to Improve Renal Anemia and Fibrosis;The American Journal of Chinese Medicine;2024-07-30

3. Epiberberine inhibits bone metastatic breast cancer-induced osteolysis;Journal of Ethnopharmacology;2024-06

4. Schisandrin B ameliorates adjuvant-induced arthritis in rats via modulation of inflammatory mediators, oxidative stress, and HIF-1α/VEGF pathway;Journal of Pharmacy and Pharmacology;2024-02-29

5. The miR-19a/Cylindromatosis Axis Regulates Pituitary Adenoma Bone Invasion by Promoting Osteoclast Differentiation;Cancers;2024-01-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3